These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance. Lee JH; Bae IK; Lee SH Med Res Rev; 2012 Jan; 32(1):216-32. PubMed ID: 20577973 [TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
5. [Broad-spectrum beta-lactamases in Gram-negative bacteria]. Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum beta-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria. Stürenburg E; Lang M; Horstkotte MA; Laufs R; Mack D J Antimicrob Chemother; 2004 Nov; 54(5):870-5. PubMed ID: 15471997 [TBL] [Abstract][Full Text] [Related]
8. What's new in antibiotic resistance? Focus on beta-lactamases. Babic M; Hujer AM; Bonomo RA Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402 [TBL] [Abstract][Full Text] [Related]
10. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases. Shah AA; Hasan F; Ahmed S; Hameed A Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058 [TBL] [Abstract][Full Text] [Related]
11. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Bradford PA Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791 [TBL] [Abstract][Full Text] [Related]
15. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens. Helfand MS; Bonomo RA Curr Opin Pharmacol; 2005 Oct; 5(5):452-8. PubMed ID: 16084766 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Drieux L; Brossier F; Sougakoff W; Jarlier V Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532 [TBL] [Abstract][Full Text] [Related]
17. A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers. Marchiaro P; Ballerini V; Spalding T; Cera G; Mussi MA; Morán-Barrio J; Vila AJ; Viale AM; Limansky AS J Antimicrob Chemother; 2008 Aug; 62(2):336-44. PubMed ID: 18456651 [TBL] [Abstract][Full Text] [Related]
19. A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Voets GM; Fluit AC; Scharringa J; Cohen Stuart J; Leverstein-van Hall MA Int J Antimicrob Agents; 2011 Apr; 37(4):356-9. PubMed ID: 21353487 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]